Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: PRognostic factor of Early Death In phase II Trials or the end of ‘sufficient life expectancy’ as an inclusion criterion? (PREDIT model)

Fig. 1

Overall survival in the two sets. a Overall survival in the Center 1 set (blue) and Center 2 set (red). b Survival depending on the presence (dotted lines) or absence (full lines) of ‘life expectancy’ criterion for each patient included regarding the respective trial’s protocol, in the Center 1set (blue) and Center 2 set (red)

Back to article page